Company intelligence / Profile preview

Advanced Research Center

Darmstadt, Hessen, Germanyarctrials.com ↗

Ownership: Private
Employees: ~63000
Development stage: Phase 1

Overview

The Advanced Research Center (ARC) at Merck KGaA’s global headquarters in Darmstadt brings together research on key life science technologies to accelerate biopharmaceutical product development. The €300 million investment focuses on raw materials/processes for antibodies, recombinant proteins, viral vectors (for gene therapy/vaccines), cell culture media/formulation aids/digital reference materials/analytical chromatography/mRNA value chain. The site enables cross-departmental collaboration with nearly carbon-neutral operations. It underpins Merck’s leadership as a global supplier to pharma/biotech companies developing therapies for cancer, autoimmune disease and infectious disease.

Modalities: AntibodyRecombinant proteinViral vectormRNA-based drugs
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Advanced Research Center.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Advanced Research Center.

Explore the full profile